EurekaMag.com logo
+ Translate

New gene finding may yield clues to prostate cancer complexity


, : New gene finding may yield clues to prostate cancer complexity. Journal of the National Cancer Institute 93(5): 344-345


(PDF 0-2 workdays service)

Accession: 046794654

PMID: 11238695

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Matikainen, M.P.; Schleutker, J.; Koivisto, P.A.; Ikonen, T.; Tammela, T.L.J.; Sankila, R.; Pukkala, E.; Baffoe Bonnie, A.; Smith, J.R.; Kainu, T.; Bailey Wilson, J.E.; Trent, J.M.; Kallioniemi, O.P., 2000: Genetic and epidemiological clues to prostate cancer Genetic predisposition to late-onset prostate cancer and identification of a prostate-gastric cancer association in a nation-wide cancer registry study in Finland. Journal of Urology 163(4 Suppl ): 28, April

Bankhead, C., 1996: Clues to prostate cancer gene are few, but possibilities emerge. Journal of the National Cancer Institute 88(1): 11-12

Cremers, R.G.; Eeles, R.A.; Bancroft, E.K.; Ringelberg-Borsboom, J.; Vasen, H.F.; Van Asperen, C.J.; Schalken, J.A.; Verhaegh, G.W.; Kiemeney, L.A.; Aaronson, N.; Ardem-Jones, A.; Bancroft, E.K.; Bangma, C.; Castro, E.; Dearnaley, D.; Eccles, D.; Eeles, R.A.; Evans, D.G.; Eyfjord, J.; Falconer, A.; Foster, C.S.; Grönberg, H.; Hamdy, F.C.; Johansson, O.; Khoo, V.; Kote-Jarai, Z.; Lilja, H.; Lubinski, J.; Maehle, L.; Melia, J.; Mikropoulos, C.; Mitchell, G.; Mitra, A.V.; Moss, S.; Moynihan, C.; R, 2016: The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers. To evaluate the additive value of the prostate cancer gene 3 (PCA3) urine test to serum prostate-specific antigen (PSA) in prostate cancer (PC) screening among breast cancer, early-onset gene (BRCA) mutation carriers. This study was performed amon...

D.L.ca, S.; Passera, R.; Bollito, E.; Manfredi, M.; Scarpa, R.Mario.; Sottile, A.; Randone, D.Franco.; Porpiglia, F., 2015: Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. To determine if prostate cancer gene 3 (PCA3) score, Prostate Health Index (PHI), and percent free prostate-specific antigen (%fPSA) may be used to differentiate prostatitis from prostate cancer (PCa), benign prostatic hyperplasia (BPH) and high-g...

Ifere, G.O.; Ananaba, G.A., 2009: Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression. The search for a classic biomarker for prostate cancer has been on for a very long time, and it is still elusive. Despite the extensive and prolonged use of the prostate-specific antigen (PSA) as a screening tool for prostate cancer, many clinicia...

Anonymous, 2012: New finding gives clues for overcoming tamoxifen-resistant breast cancer. A University of Cincinnati cancer biology team reports breakthrough findings about specific cellular mechanisms that may help overcome endocrine (hormone) therapy-resistance in patients with estrogen-positive breast cancers, combating a widespread...

Ekane, S.; Zlotta, A.R.; Roumeguere, T.; Schulman, C.C.; Djavan, B.; Marberger, M., 2000: Is one set of sextant biopsies enough to rule out prostate cancer? A prospective study on the influence of transition and total prostate volumes on prostate cancer yield. Journal of Urology 163(4 Suppl ): 90, April

Djavan, B.; Zlotta, A.R.; Ekane, S.; Remzi, M.; Kramer, G.; Roumeguère, T.; Etemad, M.; Wolfram, R.; Schulman, C.C.; Marberger, M., 2000: Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield. Purpose: Although the sextant biopsy technique has been widely used, concern has arisen that this method may not include an adequate sampling of the prostate, especially for large prostate volumes. We conducted a multicenter study in patients with...

Grizzi, F.; Chiriva-Internati, M., 2006: Cancer: looking for simplicity and finding complexity. Cancer is one of the most complex dynamic human disease. Despite rapid advances in the fields of molecular and cell biology, it is still widely debated as to how neoplastic cells progress through carcinogenesis and acquire their metastatic ability...

Nagy, P.; Jenei, A.; Damjanovich, S.; Jovin, T.M.; Szölôsi, J., 1999: Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy. The erbB2 oncogene belongs to the type I trans-membrane tyrosine kinase family of receptors. Its medical importance stems from its widespread over-expression in breast cancer. This review will focus on the signal transduction through this protein,...